Allos Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Allos Therapeutics?

Allos Therapeutics is funded by Aisling Capital.

Overview

Allos Therapeutics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Allos Therapeutics

CB Rank

314309

Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics.

Acquired by

Spectrum Pharmaceuticals

Founded

obfuscation

Private

Private Equity

Berkeley, California, United States

101-250

www.allos.com/

Biotechnology

Health Care

Funding Rounds

Private Equity

OBF

obfuscation

Details

Legal Name

Allos Therapeutics, Inc

Operating Status

Active

Company Type

For Profit

About the Company

Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics. FOLOTYN, the company’s main product is a folate analogue metabolic inhibitor design to accumulate preferentially in cancer cells so as to cause cell death.

Allos Therapeutics was founded in 1992 and is headquartered in Westminster,

Colorado. As of September 4, 2012, Allos Therapeutics operates as a subsidiary of Spectrum Pharmaceuticals, Inc.

Phone Number

(303)426-6262

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Causal AI

A causal reasoning AI model that identifies cause-effect relationships in clinical variables to predict outcomes in interventional studies.

Drug Development and Licensing

Services for co-developing and licensing drugs, including novel formulations and clinical-stage assets.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Allos Therapeutics	1	obfuscated obfuscation	Aisling Capital	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Aisling Capital	Yes	Private Equity Round - Allos Therapeutics	—
Aisling Capital	Yes	Private Equity Round - Allos Therapeutics	—
Aisling Capital	Yes	Private Equity Round - Allos Therapeutics	—
Aisling Capital	Yes	Private Equity Round - Allos Therapeutics	—
Aisling Capital	Yes	Private Equity Round - Allos Therapeutics	—

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation
obfuscated obfuscation	N-Gene	Yes	Corporate Round - N-Gene	obfuscated obfuscation